Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane Serine Protease 2 (TMPRSS2) is a type II transmembrane serine protease that plays a critical role in viral entry and prostate cancer. It is highly expressed in epithelial tissues, including the respiratory tract and prostate. TMPRSS2 facilitates viral entry by cleaving and activating viral envelope glycoproteins, such as the SARS-CoV-2 spike protein. In prostate cancer, TMPRSS2 can fuse with ETS transcription factors, leading to overexpression of oncogenic ETS factors. TMPRSS2 is a therapeutic target for antiviral drug development and a biomarker/fusion partner gene in oncology research.
Inhibition of serine protease activity; cleavage prevention of viral spike protein.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane Serine Protease 2 (None).